Kidney and cardiovascular disease
Marín, R.
Nefrologia Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 17-20
2004
ISSN/ISBN: 0211-6995 PMID: 15696892 Document Number: 582921
Document emailed within 1 workday
Related Documents
Chitalia, N.; Raja, R.B.; Bhandara, T.; Agrawal, P.; Kaski, J.C.; Jha, V.; Banerjee, D. 2010: Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation Journal of Nephrology 23(1): 77-84Zhang, X.; Hou, F.-f. 2010: Calcium and phosphorus metabolism and cardiovascular disease in chronic kidney disease Zhonghua Nei Ke Za Zhi 49(7): 555-557
Ishii, H.; Murohara, T. 2011: Interventional revascularization for cardiovascular disease in patients with chronic kidney disease Nihon Rinsho. Japanese Journal of Clinical Medicine 69(2): 339-342
Mahajan, A.; Qiu, J.; Stark, P.C.; Persson, R.; Kwack, C.; Levey, A.S.; Stevens, L.A. 2009: Prevalence of ICD-9-CM codes for chronic kidney disease in individuals with cardiovascular disease risk factors Journal of Nephrology 22(4): 523-533
Quoc Hoang, T.A.; Tam, V.; Thang, H.V. 2019: Plasma asymmetric dimethylarginine and its association with some of cardiovascular disease risk factors in chronic kidney disease Medical Journal of Malaysia 74(3): 209-214
Hjelmesaeth, J.; Midtvedt, K.; Aakhus, S.; Hartmann, A. 1999: Cardiovascular disease after kidney transplantation Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(25): 3784-3788
Coen, G.; Manni, M.; Mantella, D.; Splendiani, G. 2006: Can cardiovascular calcifications be prevented in chronic kidney disease? Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 23 Suppl. 34: S21-S25
Goicoechea, M.A. 2004: Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 142-160; 187-235
Handa, S.P. 2006: Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults Clinical and Investigative Medicine. Medecine Clinique et Experimentale 29(6): 339-346
1992: ACE inhibitors and end-organ damage in cardiovascular disease: kidney and nervous system in hypertension. Proceedings of the Erasmus Medical Workshops Journal of Cardiovascular Pharmacology 19 Suppl. 6: S1-145
Schrager, S.; Dalby, J.; Hayon, R.; Fox, K. 2013: Cardiovascular disease in women: contraceptive issues and nonvalvular cardiovascular disease Fp Essentials 411: 28-33
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Schmitt, M.F.; Noronha, I.; Jäger, T.; Ritz, E.; Waldherr, R. 1989: Acquired cystic kidney disease and autosomal dominant polycystic kidney disease--precancerous condition? Verhandlungen der Deutschen Gesellschaft für Pathologie 73: 428-435
Isshiki, K.; Haneda, M.; Koya, D.; Kikkawa, R. 2000: Kidney disease and insulin resistance--clinical impact of thiazolidinedione compounds for kidney disease Nihon Rinsho. Japanese Journal of Clinical Medicine 58(2): 440-445
Kes, P.; Slavicek, J. 2013: Hepatitis C virus and chronic progressive kidney disease. Guidelines for detection, evaluation, treatment and prevention of infection transmission in hemodialysis units; procedure for infected patients-candidates for kidney transplantation and procedure for patients suspected of HCV infection-related kidney disease Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 67(4): 361-366
Alvarez Navascués, R.; Quiñones, L.; Guinea, O.F.; Guerediaga, F. 2005: Caroli disease in a kidney transplant patient with polycystic kidney disease Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 25(3): 336-337
Thorogood, M. 1993: Anticonceptivos orales y enfermedad cardiovascular - Oral contraceptives and cardiovascular disease Beneficios y Riesgos de la Anticoncepcion Oral. Simposio (Caracas 1992-11) 9: 19-29
1991: Relation of cholesterol level to cardiovascular mortality among men with and without preexisting cardiovascular disease New England Journal of Medicine 324(1): 60-61
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6